79-92-5 | Sigma-Aldrich

Integritest® 5 OPC-UA Automation User Guide

Also Integritest® 5 OPC-UA Automation User Guide 8 Configuration and Control Test Controller Results Monitor 10 47 79 Integritest® 5

Quantitative multiplex analysis of 48 analytes using the MILLIPLEX®Human Cytokine/Chemokine/Growth Factor Panel

G-CSF GM-CSF HCYTA-60K 100 92 100 81 100 86 92 67 HCYTOMAG-60K 100 92 100 81 25 11 97 92 GROα* IFNα2 IFNγ IL-1α IL-1β IL-1RA IL-2 IL-3 HCYTA-60K 83 72 92 83 92 100 47

Product Information sheet - N2770

World Health Organ., 53(1), 55-65 (1976). 2. Jones, J.V. et al., J. Immunol. Methods, 118(1), 79-84 (1989). 3. Honda, Y. et al., Vaccine, 16(13), 1276-1282 (1998). 4. Tibbett, M. et al.

PKH Dye Reference Guide

Jayaraman S, Soukiasian S, Dorf M, Foster CS: [Glycoprotein D (5-23) specific Th2-T-cell line induces HSV-1 keratitis]. Ophthalmologe. 1995; 92: 484-491. 76. Johann S, Blumel G, Lipp M, Forster R:

Human Soluble Cytokine Receptor Panel

sgp130 63 sIL-1RI 65 sIL-1RII 69 sIL-2Rα 76 sIL-4R 77 sIL-6R 79 sRAGE 81 sTNFRI 83 sTNFRII 85 sVEGFR1 88 sVEGFR2 90 sVEGFR3 92 QUALITY CONTROLS The

Iodine in drinking water, wastewater and disinfection solutions

Specialty Monomers For Ophthalmic Applications Brochure

production 7558-79-4 Sodium Phosphate Monobasic Monohydrate PharmaGrade, USP, manufactured under appropriate GMP controls for pharma or biopharmaceutical production 10049-21-5 Sodium Tetraborate

D-Tubes and U-Tubes Profiler

-3 71507-3 66 66 80 80 Maxi† 100 to 3000 3.5 6–8 12–14 71508-3 71509-3 71510-3 79 79 79 99 99 99 Product Size Cat. No. Price £ Price € Floating Rack, Mini 10 racks 71512-3 9 14

Protocol: Human PYY (Total) ELISA Kit - 96-Well Plate

0 (Basal) 92 -- 104 -- 40 128 90% 145 103% 100 171 79% 201 97% 500 511 84% 647 109% F 0 (Basal)

Protocol- EZHPYTT66K

83% 700 106% D 0 (Basal) 92 - 104 - 40 128 90% 145 103% 100 171 79% 201 97% 500 511 84% 647 109% F 0 (Basal) 75 - 78 -

Bioactive Lipids Technical Bulletin

. 47, 833. 30. Berger, A., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 5885. 31. Dettbarn, C., et al. 1995. Brain Res. 669, 79. hydrolyzes glycerophospholipids at the sn-2 position yield

Novabiochem Letters 01/05

(1:20:79) for 225 min gave only 9% product when X=OtBu compared to 34% when X=OMpe (see Table 1) [16]. 04-12-1259 Fmoc-Asp(OMpe)-OH 1 g NEW 5 g 04-12-1235 Fmoc-Asp(OtBu)-(Hmb)Gly-OH 1 g 5 g peptide

Product Information Sheet-11585592001

Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim Germany 5. Supplementary Information 11 20 .1 15 88 92 30 01 12 5.4. Trademarks All product names and trademarks are the

Supel Tox SPE Cartridges brochure

Acetyldeoxynivalenol 5 mg 32927 15-Acetyldeoxynivalenol 5 mg 32928 Aflatoxin B1 5 mg 32754* Aflatoxin B2 5 mg 32755 Aflatoxin G1 5 mg 32756 Aflatoxin G2 5 mg 32757* Deoxynivalenol 5 mg 32943 Fumonisin B1 5 mg 32936

GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor

al., J. Biol. Chem., 278, 19183-19189 (2003). 78. Liu, K., et al., J. Virol., 69, 7823-7834 (1995). 79. Guan, K., et al., Nature, 350, 359-362 (1991). 80. Najarro, P., et al., J. Virol., 75, 3185-3196 (

Periodic table Poster

231.04 1572 1.14 Pa 4, 5 [Rn] 5f26d17s2 92 *238.03 1135 4131 1.22 U 3, 4, 5, 6 [Rn] 5f36d17s2 93 *237.05 644 3902 1.22 Np 3

Periodic table A4

231.04 1572 1.14 Pa 4, 5 [Rn] 5f26d17s2 92 *238.03 1135 4131 1.22 U 3, 4, 5, 6 [Rn] 5f36d17s2 93 *237.05 644 3902 1.22 Np 3

Chromatographic Purification of Plasmid DNA

52 0 2. 58 9 2. 63 2 2. 92 2 5. 03 5 5. 38 4 5. 49 7 5 .7 70 oc _D N A 6. 42 1

Inactivación de desinfectantes utilizando placas de contacto ICR con medio de cultivo TSA con diferentes neutralizantes

neutralizantes incluídos. 5 Neutralización del concentrado de Anioxy Spore-Twin IP estéril 139 167 93 119 99 167 104

Product Information Sheet - BAMHIRO

& Manta, V. (1990) Gene 92, 1–248. 3 George, J.&Chirikjian, J.G.(1982) Proc. Natl. Acad. Sci. USA 79, 2432. 4 Kolesnikov, V. A. et al. (1981) FEBS Lett. 132, 101. 5 Rebase The Restriction

Biological Evaluation of the MILLIPLEX®MAPMouse High Sensitivity T Cell Panel

IL-12 (p70) 63 IL-1α 100 IL-13 100 IL-1β 56 LIX 100 IL-2 93 62 IL-17A 100 IL-4 100 79 KC 100 IL-5 88 MCP-1 100 IL-6 75 100 MIP-2 88

Anios Application Note

dilution according to manufacturer’s instruction) 139 167 93 119 99 167 104 98 86 79 105 113 R ec ov er y (% ) Microorganism 200 160

Protocol: Rat/ Mouse Insulin ELISA Kit

2 2.86 90 5 5.88 96 Rat Serum # 2 0 1.07 -- 0.5 1.53 92 2 2.95 94 5 6.01 99

Protocol- EZRMI-13K

1.57 102 2 2.86 90 5 5.88 96 Rat Serum #2 0 1.07 - 0.5 1.53 92 2 2.95 94 5 6.01 99 Rat

Biological Evaluation of the MILLIPLEX®MAP Mouse High Sensitivity T Cell Panel

IL-12 (p70) 63 IL-1α 100 IL-13 100 IL-1β 56 LIX 100 IL-2 93 62 IL-17A 100 IL-4 100 79 KC 100 IL-5 88 MCP-1 100 IL-6 75 100 MIP-2 88

Samplicity®Filtration System

100 µL 78 14 Waters 186001127 100 µL 76 7 Verex AR0-3625-12 100 µL 79 2 Restek 22439 100 µL 82 2 Restek 22433 100 µL 82 5 Waters 186002642 High recovery of small volume

Fuel the future - ANALYTICAL SOLUTIONS FOR THE PETROCHEMICAL INDUSTRY

43 44 45 46 4748 49 50 59 71 72 73 74 7577 78 79 80 81 82 84 85 86 87 88 89 90 91 92 93 95

Protocol: Glucagon-Like Peptide-1 (Total) RIA Kit

3 50 57 66 86 4 100 92 116 79 1 0 40 - - 2 10 55 50 110 3 50 90 90 100

Product Information Sheet - MPAA3

77 2 1 4 1 Phospholipase A2,Secretory Group V 78 2 1 4 2 Phospholipase A2,Secretory Group V 79 2 1 4 3 BSA 80 2 1 4 4 Positive 81 2 2 1 1 Phospholipase Cγ1 (PLCγ1) 82 2 2 1 2 Phospholipase

Protocol: Mouse FGF-23 ELISA

3.37 2.94 87 5 1.685 1.42 84 2.5 0.842 0.67 80 2 20 5.3 10 2.65 2.87 108 5 1.325 1.22 92